FMC LAW LTD

Company number 06340985 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

Financial Health Assessment: FMC LAW LTD

1. Financial Health Score: D-

Explanation: The business is not experiencing typical financial distress; rather, it is in a state of terminal decline. The company's regulatory licence to practice law was revoked in May 2024, and it has ceased taking on new business. The dramatic collapse in cash reserves and the halving of the workforce are not symptoms of a struggling business trying to survive, but rather of a business actively winding down. While the remaining net assets are positive, the company's operational heartbeat has flatlined.


2. Key Vital Signs

  • Cash Flow (Blood Pressure): Critical Hypotension. Cash at bank has haemorrhaged from £4.4 million in 2023 to just £103,000 in 2024. A 97% drop in liquidity indicates that cash is being aggressively drained from the business, likely through the distribution of retained profits or the repayment of client funds.
  • Net Assets (Muscle Mass): Severe Atrophy. Net assets have deteriorated from a peak of £19.4 million in 2019 to £1.67 million in 2024. While the patient is still technically alive and has a positive net worth, it has shed the vast majority of its financial bulk.
  • Operations (Heartbeat): Flatline. The average employee count dropped from 26 to 14, and multiple directors (name shown to subscribers, name shown to subscribers, name shown to subscribers) resigned in early 2024. Most critically, the firm's Solicitors Regulation Authority (SRA) licence ceased effect on May 16, 2024. The core function of the business has stopped.
  • Investments (Organ Transplant): The company has shifted £1.55 million into unlisted investments during the 2024 period. Capital is being moved out of the operating law firm and parked elsewhere, suggesting a pivot or restructuring of assets prior to the firm's closure.
  • Creditors (Cholesterol Levels): Clear. Current liabilities are remarkably low at just £11,983. The company is not drowning in debt, making the wind-down process cleaner.

3. Diagnosis

Terminal Wind-Down with Balance Sheet Detox

The financial data reveals a company that is undergoing an aggressive, planned closure rather than suffering from a sudden corporate illness. The massive historical assets (peaking at over £21 million in 2018/2019) were likely heavily inflated by client monies held in the firm's client accounts—a standard practice for law firms. As the firm winds down, these client funds are being returned, which artificially makes the balance sheet look like it is collapsing.

The real symptom of distress occurred in May 2024 when the SRA licence was revoked. This means the company can no longer generate new revenue from legal services. The remaining £1.67 million in net assets is primarily comprised of a £1.54 million unlisted investment and outstanding debtor balances (£45k), with very little cash left to sustain ongoing administrative overheads. The patient has decided to stop breathing; the question now is how orderly the passing will be.


4. Recommendations

  • Palliative Care for Client Matters: The absolute priority must be ensuring all remaining client funds are properly distributed and that former clients' files are securely archived or transferred. Failing to do this invites regulatory action from the SRA, even post-closure.
  • Liquidate Remaining Debtors: The £45,392 owed to the company by debtors needs to be collected aggressively before staff resources are fully depleted. Once the remaining 14 employees depart, collection will become significantly harder.
  • Monitor the Unlisted Investment: The £1.54 million unlisted investment now represents the vast majority of the company's value. Shareholders must ensure this investment is properly valued, easily liquidatable, and protected from any potential liabilities arising from the closure of the legal practice.
  • Formal Closure Strategy: Given the positive net assets and the cessation of trade, the shareholders should consider a formal Members' Voluntary Liquidation (MVL) to extract the remaining investment value in a tax-efficient manner, rather than allowing the company to simply sit dormant with ongoing compliance costs.

Names of the people mentioned are shown to subscribers. See subscription

Perspective: Financial Health Diagnostician · Model: glm-5.1 · Generated 22 July 2026